Anti-inflammatory mechanisms and therapeutic opportunities in myocardial infarct healing

Journal of Molecular Medicine

Volumn 90, Issue 4, 2012, Pages 361-369

  Kempf, Tibor ^a   Zarbock, Alexander ^b,c   Vestweber, Dietmar ^c   Wollert, Kai C ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

Author keywords

Heart failure; Infarct expansion; Infarct rupture; Inflammation; Myocardial infarction

Indexed keywords

GROWTH DIFFERENTIATION FACTOR 15; INTERLEUKIN 10; SECRETED FRIZZLED RELATED PROTEIN 1; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; CONTROLLED STUDY; HEART FAILURE; HEART INFARCTION; INFLAMMATION; INFLAMMATORY CELL; MOUSE; NONHUMAN; REVIEW; WOUND HEALING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; HEART; HUMANS; INFLAMMATION; MYOCARDIAL INFARCTION; MYOCARDIUM; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 84862537276     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-011-0847-y     Document Type: Review

References (68)

1. Velagaleti RS, Pencina MJ, Murabito JM, Wang TJ, Parikh NI, D'Agostino RB, Levy D, Kannel WB, Vasan RS (2008) Long-term trends in the incidence of heart failure after myocardial infarction. Circulation 118:2057-2062
2. Arslan F, de Kleijn DP, Pasterkamp G (2011) Innate immune signaling in cardiac ischemia. Nat Rev Cardiol 8:292-300
3. Eltzschig HK, Eckle T (2011) Ischemia and reperfusion-from mechanism to translation. Nat Med 17:1391-1401
4. Wrigley BJ, Lip GY, Shantsila E (2011) The role of monocytes and inflammation in the pathophysiology of heart failure. Eur J Heart Fail 13:1161-1171
5. Dirksen MT, Laarman GJ, Simoons ML, Duncker DJ (2007) Reperfusion injury in humans: A review of clinical trials on reperfusion injury inhibitory strategies. Cardiovasc Res 74:343-355 (Pubitemid 46693697)
6. Yellon DM, Hausenloy DJ (2007) Myocardial reperfusion injury. N Engl J Med 357:1121-1135
7. Heymans S, Hirsch E, Anker SD, Aukrust P, Balligand JL, Cohen- Tervaert JW, Drexler H, Filippatos G, Felix SB, Gullestad L et al (2009) Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 11:119-129
8. Frangogiannis NG (2008) The immune system and cardiac repair. Pharmacol Res 58:88-111
9. Eaton LW,Weiss JL, Bulkley BH, Garrison JB,WeisfeldtML (1979) Regional cardiac dilatation after acute myocardial infarction: Recognition by two-dimensional echocardiography. N Engl JMed 300:57-62 (Pubitemid 9104309)
10. Kelle S, Roes SD, Klein C, Kokocinski T, de Roos A, Fleck E, Bax JJ, Nagel E (2009) Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging. J Am Coll Cardiol 54:1770-1777
11. Gao XM, Xu Q, Kiriazis H, Dart AM, Du XJ (2005) Mouse model of post-infarct ventricular rupture: Time course, strain- and genderdependency, tensile strength, and histopathology. Cardiovasc Res 65:469-477 (Pubitemid 40082489)
12. van den Borne SW, van de Schans VA, Strzelecka AE, Vervoort- Peters HT, Lijnen PM, Cleutjens JP, Smits JF, Daemen MJ, Janssen BJ, Blankesteijn WM (2009) Mouse strain determines the outcome of wound healing after myocardial infarction. Cardiovasc Res 84:273-282
13. Figueras J, Barrabes JA, Serra V, Cortadellas J, Lidon RM, Carrizo A, Garcia-Dorado D (2010) Hospital outcome of moderate to severe pericardial effusion complicating ST-elevation acute myocardial infarction. Circulation 122:1902-1909
14. Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L, Dyspersin GD, Cleutjens JP, Shipley M, Angellilo A et al (1999) Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 5:1135-1142 (Pubitemid 29474417)
15. Matsumura S, Iwanaga S, Mochizuki S, Okamoto H, Ogawa S, Okada Y (2005) Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice. J Clin Invest 115:599-609 (Pubitemid 40322234)
16. van den Borne SW, Cleutjens JP, Hanemaaijer R, Creemers EE, Smits JF, Daemen MJ, Blankesteijn WM (2009) Increased matrix metalloproteinase-8 and -9 activity in patients with infarct rupture after myocardial infarction. Cardiovasc Pathol 18:37-43
17. Ichihara S, Senbonmatsu T, Price E Jr, Ichiki T, Gaffney FA, Inagami T (2002) Targeted deletion of angiotensin II type 2 receptor caused cardiac rupture after acute myocardial infarction. Circulation 106:2244-2249 (Pubitemid 35222220)
18. Shimazaki M, Nakamura K, Kii I, Kashima T, Amizuka N, Li M, Saito M, Fukuda K, Nishiyama T, Kitajima S et al (2008) Periostin is essential for cardiac healing after acute myocardial infarction. J Exp Med 205:295-303 (Pubitemid 351281595)
19. Westermann D, Mersmann J, Melchior A, Freudenberger T, Petrik C, Schaefer L, Lullmann-Rauch R, Lettau O, Jacoby C, Schrader J et al (2008) Biglycan is required for adaptive remodeling after myocardial infarction. Circulation 117:1269-1276 (Pubitemid 351365659)
20. Schellings MW, Vanhoutte D, Swinnen M, Cleutjens JP, Debets J, van Leeuwen RE, d'Hooge J, Van de Werf F, Carmeliet P, Pinto YM et al (2009) Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction. J Exp Med 206:113-123
21. Matsui Y, Ikesue M, Danzaki K, Morimoto J, Sato M, Tanaka S, Kojima T, Tsutsui H, Uede T (2011) Syndecan-4 prevents cardiac rupture and dysfunction after myocardial infarction. Circ Res 108:1328-1339
22. van den Borne SW, Diez J, Blankesteijn WM, Verjans J, Hofstra L, Narula J (2010) Myocardial remodeling after infarction: The role of myofibroblasts. Nat Rev Cardiol 7:30-37
23. Vanhoutte D, Schellings MW, Gotte M, Swinnen M, Herias V, Wild MK, Vestweber D, Chorianopoulos E, Cortes V, Rigotti A et al (2007) Increased expression of syndecan-1 protects against cardiac dilatation and dysfunction after myocardial infarction. Circulation 115:475-482 (Pubitemid 46184199)
24. Frangogiannis NG, Ren G, Dewald O, Zymek P, Haudek S, Koerting A, Winkelmann K, Michael LH, Lawler J, Entman ML (2005) Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts. Circulation 111:2935-2942 (Pubitemid 40814186)
25. Bulkley BH, Roberts WC (1974) Steroid therapy during acute myocardial infarction. A cause of delayed healing and of ventricular aneurysm. Am J Med 56:244-250
26. Roberts R, DeMello V, Sobel BE (1976) Deleterious effects of methylprednisolone in patients with myocardial infarction. Circulation 53:I204-I206
27. Fazel S, Cimini M, Chen L, Li S, Angoulvant D, Fedak P, Verma S, Weisel RD, Keating A, Li RK (2006) Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest 116:1865-1877 (Pubitemid 44033311)
28. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL, Libby P, Weissleder R, Pittet MJ (2007) The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 204:3037-3047 (Pubitemid 350179569)
29. Jujo K, Hamada H, Iwakura A, Thorne T, Sekiguchi H, Clarke T, Ito A, Misener S, Tanaka T, Klyachko E et al (2010) CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction. Proc Natl Acad Sci USA 107:11008-11013
30. Nahrendorf M, Pittet MJ, Swirski FK (2010) Monocytes: Protagonists of infarct inflammation and repair after myocardial infarction. Circulation 121:2437-2445
31. Tsujioka H, Imanishi T, Ikejima H, Kuroi A, Takarada S, Tanimoto T, Kitabata H, Okochi K, Arita Y, Ishibashi K et al (2009) Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction. J Am Coll Cardiol 54:130-138
32. Panizzi P, Swirski FK, Figueiredo JL, Waterman P, Sosnovik DE, Aikawa E, Libby P, Pittet M, Weissleder R, Nahrendorf M (2010) Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis. J Am Coll Cardiol 55:1629-1638
33. Leuschner F, Panizzi P, Chico-Calero I, Lee WW, Ueno T, Cortez- Retamozo V, Waterman P, Gorbatov R, Marinelli B, Iwamoto Yet al (2010) Angiotensin-converting enzyme inhibition prevents the release of monocytes from their splenic reservoir in mice with myocardial infarction. Circ Res 107:1364-1373
34. Fraccarollo D, Galuppo P, Schraut S, Kneitz S, van Rooijen N, Ertl G, Bauersachs J (2008) Immediate mineralocorticoid receptor blockade improves myocardial infarct healing by modulation of the inflammatory response. Hypertension 51:905-914 (Pubitemid 351654703)
35. Harel-Adar T, Ben Mordechai T, Amsalem Y, Feinberg MS, Leor J, Cohen S (2011) Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair. Proc Natl Acad Sci USA 108:1827-1832
36. Curato C, Slavic S, Dong J, Skorska A, Altarche-Xifro W, Miteva K, Kaschina E, Thiel A, Imboden H, Wang J et al (2010) Identification of noncytotoxic and IL-10-producing CD8+AT2R+T cell population in response to ischemic heart injury. J Immunol 185:6286-6293
37. Dobaczewski M, Xia Y, Bujak M, Gonzalez-Quesada C, Frangogiannis NG (2010) CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells. Am J Pathol 176:2177-2187
38. Zymek P, Nah DY, Bujak M, Ren G, Koerting A, Leucker T, Huebener P, Taffet G, Entman M, Frangogiannis NG (2007) Interleukin-10 is not a critical regulator of infarct healing and left ventricular remodeling. Cardiovasc Res 74:313-322 (Pubitemid 46517506)
39. Krishnamurthy P, Lambers E, Verma S, Thorne T, Qin G, Losordo DW, Kishore R (2010) Myocardial knockdown of mRNAstabilizing protein HuR attenuates post-MI inflammatory response and left ventricular dysfunction in IL-10-null mice. FASEB J 24:2484-2494
40. Krishnamurthy P, Rajasingh J, Lambers E, Qin G, Losordo DW, Kishore R (2009) IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. Circ Res 104:e9-e18
41. Barandon L, Casassus F, Leroux L, Moreau C, Allieres C, Lamaziere JM, Dufourcq P, Couffinhal T, Duplaa C (2011) Secreted frizzledrelated protein-1 improves postinfarction scar formation through a modulation of inflammatory response. Arterioscler Thromb Vasc Biol 31:e80-e87
42. LaeremansH,Hackeng TM, van ZandvoortMA, ThijssenVL, Janssen BJ, Ottenheijm HC, Smits JF, Blankesteijn WM (2011) Blocking of frizzled signaling with a homologous peptide fragment of wnt3a/wnt5a reduces infarct expansion and prevents the development of heart failure after myocardial infarction. Circulation 124:1626-1635
43. Bujak M, Dobaczewski M, Gonzalez-Quesada C, Xia Y, Leucker T, Zymek P, Veeranna V, Tager AM, Luster AD, Frangogiannis NG (2009) Induction of the CXC chemokine interferon-?-inducible protein 10 regulates the reparative response following myocardial infarction. Circ Res 105:973-983
44. Ikeuchi M, Tsutsui H, Shiomi T, Matsusaka H, Matsushima S,Wen J, Kubota T, Takeshita A (2004) Inhibition of TGF-β signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction. Cardiovasc Res 64:526-535 (Pubitemid 39505431)
45. Bujak M, Frangogiannis NG (2007) The role of TGF-β signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 74:184-195 (Pubitemid 46517504)
46. Kempf T, Zarbock A, Widera C, Butz S, Stadtmann A, Rossaint J, Bolomini-Vittori M, Korf-Klingebiel M, Napp LC, Hansen B et al (2011) GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice. Nat Med 17:581-588
47. Kempf T, Eden M, Strelau J, Naguib M, Willenbockel C, Tongers J, Heineke J, Kotlarz D, Xu J, Molkentin JD et al (2006) The transforming growth factor-β superfamily member growthdifferentiation factor-15 protects the heart from ischemia/reperfusion injury. Circ Res 98:351-360
48. Puri KD, Doggett TA, Huang CY, Douangpanya J, Hayflick JS, Turner M, Penninger J, Diacovo TG (2005) The role of endothelial PI3K? activity in neutrophil trafficking. Blood 106:150-157 (Pubitemid 40967187)
49. Hirsch E, Ciraolo E, Ghigo A, Costa C (2008) Taming the PI3K team to hold inflammation and cancer at bay. Pharmacol Ther 118:192-205
50. Siragusa M, Katare R, Meloni M, Damilano F, Hirsch E, Emanueli C, Madeddu P (2010) Involvement of phosphoinositide 3-kinase ? in angiogenesis and healing of experimental myocardial infarction in mice. Circ Res 106:757-768
51. Dewald O, Zymek P, Winkelmann K, Koerting A, Ren G, Abou- Khamis T, Michael LH, Rollins BJ, Entman ML, Frangogiannis NG (2005) CCL2/monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res 96:881-889 (Pubitemid 40604972)
52. Hayashidani S, Tsutsui H, Shiomi T, Ikeuchi M, Matsusaka H, Suematsu N, Wen J, Egashira K, Takeshita A (2003) Antimonocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 108:2134-2140 (Pubitemid 37337591)
53. Liehn EA, Piccinini AM, Koenen RR, Soehnlein O, Adage T, Fatu R, Curaj A, Popescu A, Zernecke A, Kungl AJ et al (2010) A new monocyte chemotactic protein-1/chemokine CC motif ligand-2 competitor limiting neointima formation and myocardial ischemia/ reperfusion injury in mice. J Am Coll Cardiol 56:1847-1857
54. Timmers L, Sluijter JP, van Keulen JK, Hoefer IE, Nederhoff MG, Goumans MJ, Doevendans PA, van Echteld CJ, Joles JA, Quax PH et al (2008) Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circ Res 102:257-264 (Pubitemid 351674064)
55. Barochia A, Solomon S, Cui X, Natanson C, Eichacker PQ (2011) Eritoran tetrasodium (E5564) treatment for sepsis: Review of preclinical and clinical studies. Expert Opin DrugMetab Toxicol 7:479-494
56. Maekawa Y, Mizue N, Chan A, Shi Y, Liu Y, Dawood S, Chen M, Dawood F, de Couto G, Li GH et al (2009) Survival and cardiac remodeling after myocardial infarction are critically dependent on the host innate immune interleukin-1 receptor-associated kinase-4 signaling: A regulator of bone marrow-derived dendritic cells. Circulation 120:1401-1414
57. Arslan F, Smeets MB, Riem Vis PW, Karper JC, Quax PH, Bongartz LG, Peters JH, Hoefer IE, Doevendans PA, Pasterkamp G et al (2011) Lack of fibronectin-EDA promotes survival and prevents adverse remodeling and heart function deterioration after myocardial infarction. Circ Res 108:582-592
58. Kohno T, Anzai T, Naito K, Miyasho T, Okamoto M, Yokota H, Yamada S, Maekawa Y, Takahashi T, Yoshikawa T et al (2009) Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling. Cardiovasc Res 81:565-573
59. Wollert KC, Drexler H (2010) Cell therapy for the treatment of coronary heart disease: A critical appraisal. Nature Reviews Cardiol 7:204-215
60. Burchfield JS, Iwasaki M, Koyanagi M, Urbich C, Rosenthal N, Zeiher AM, Dimmeler S (2008) Interleukin-10 from transplanted bone marrow mononuclear cells contributes to cardiac protection after myocardial infarction. Circ Res 103:203-211
61. Iyer SS, Rojas M (2008) Anti-inflammatory effects of mesenchymal stem cells: Novel concept for future therapies. Expert Opin Biol Ther 8:569-581 (Pubitemid 351685023)
62. Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, Semprun-Prieto L, Delafontaine P, Prockop DJ (2009) Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5:54-63
63. Wang M, Tan J, Wang Y, Meldrum KK, Dinarello CA, Meldrum DR (2009) IL-18 binding protein-expressing mesenchymal stem cells improve myocardial protection after ischemia or infarction. Proc Natl Acad Sci USA 106:17499-17504
64. Lai RC, Chen TS, Lim SK (2011) Mesenchymal stem cell exosome: A novel stem cell-based therapy for cardiovascular disease. Regen Med 6:481-492
65. Timmers L, Lim SK, Hoefer IE, Arslan F, Lai RC, van Oorschot AA, Goumans MJ, Strijder C, Sze SK, Choo A et al (2011) Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. Stem Cell Res 6:206-214
66. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, Gerstenblith G, DeMaria AN, Denktas AE, Gammon RS et al (2009) A randomized, double-blind, placebo-controlled, doseescalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 54:2277-2286
67. Dixon JA, Spinale FG (2009) Large animal models of heart failure: A critical link in the translation of basic science to clinical practice. Circ Heart Fail 2:262-271
68. Kim HW, Farzaneh-Far A, Kim RJ (2010) Cardiovascular magnetic resonance in patients with myocardial infarction. J Am Coll Cardiol 55:1-16